BridgeMD
New treatment option for Lumbar Fixation Surgery
Official title Evaluation Of Three Different Anagesic Techniques In Patients Undergoing Lumbar Fixation Surgery
ClinicalTrials.gov ID: NCT06801574
What this study is testing
- What it's testing
- Lumbar spinal stenosis is a degenerative condition characterized by the narrowing of the space surrounding the neurovascular structures of the lumbar vertebrae, resulting from age-related changes in the intervertebral discs, ligamentum flavum, and facet joints. It commonly causes unilateral pain in the lower back, hips, and legs, often described as cramping or burning.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Patients scheduled to undergo lumbar fixation surgery under general anesthesia
- aged between 18 and 65 years,
- American Society of Anesthesiologists physical status classification of I-II
You likely can't join if
- Patients with a known allergy to local anesthetics.
- Patients who used opioid analgesics within 48 hours prior to sample collection.
- Patients with a history of smoking or alcohol consumption.
- Patients with conditions affecting salivary flow, such as xerostomia or those who have undergone radiotherapy.
- Patients with infectious diseases known to be transmissible through saliva.
- Patients with an ASA physical status classification of III or higher.
See the full eligibility criteria
- Patients scheduled to undergo lumbar fixation surgery under general anesthesia
- aged between 18 and 65 years,
- American Society of Anesthesiologists physical status classification of I-II
- Patients with a known allergy to local anesthetics.
- Patients who used opioid analgesics within 48 hours prior to sample collection.
- Patients with a history of smoking or alcohol consumption.
- Patients with conditions affecting salivary flow, such as xerostomia or those who have undergone radiotherapy.
- Patients with infectious diseases known to be transmissible through saliva.
- Patients with an ASA physical status classification of III or higher.
- Patients unable to use a patient-controlled analgesia (PCA) device.
- Patients who do not consent to the study procedures.
The study team makes the final eligibility decision.
Where it's taking place
- Erzurum, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Erzurum, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.